Lemaitre Vascular (LMAT) Other Non-Current Assets (2010 - 2026)
Lemaitre Vascular (LMAT) posted quarterly Other Non-Current Assets of $5.0 million for Q1 2026, down 3.92% year-over-year from $5.2 million in Q1 2025, and up 1.3% quarter-over-quarter from $4.9 million in Q4 2025.
Lemaitre Vascular (LMAT) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has reported Other Non-Current Assets for 17 consecutive years, with $5.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Assets fell 3.92% year-over-year to $5.0 million; the TTM figure through Mar 2026 stood at $5.0 million (down 3.92% YoY), while the FY2025 annual figure was $4.9 million, up 0.78% from the prior year.
- Other Non-Current Assets advanced to $5.0 million in Q1 2026 per LMAT's latest filing, from $4.9 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $5.2 million in Q1 2025 and bottomed at $556000.0 in Q1 2022.
- Historically, Other Non-Current Assets has averaged $3.4 million across 5 years, with a median of $4.0 million in 2024.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets plunged 49.91% — and 2023, when it surged 277.4%.
- Lemaitre Vascular's Other Non-Current Assets stood at $991000.0 in 2022, then soared by 277.4% to $3.7 million in 2023, then jumped by 30.16% to $4.9 million in 2024, then advanced by 0.78% to $4.9 million in 2025, then advanced by 1.3% to $5.0 million in 2026.
- Business Quant data shows LMAT's Other Non-Current Assets at $5.0 million in Q1 2026, $4.9 million in Q4 2025, and $5.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 2.55 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 434.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 457.39 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 22.91 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 82.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 904.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 672.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 669.00 Mn |
| 10 | Lemaitre Vascular | 1.88 Bn | 1.50 Bn | 50.76 Mn | 5.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.44 Mn |
| Mar 31, 2026 | 4.97 Mn |
| Dec 31, 2025 | 4.91 Mn |
| Sep 30, 2025 | 5.03 Mn |
| Jun 30, 2025 | 5.04 Mn |
| Mar 31, 2025 | 5.17 Mn |
| Dec 31, 2024 | 4.87 Mn |
| Sep 30, 2024 | 4.23 Mn |
| Jun 30, 2024 | 4.12 Mn |
| Mar 31, 2024 | 4.01 Mn |
| Dec 31, 2023 | 3.74 Mn |
| Sep 30, 2023 | 3.15 Mn |
| Jun 30, 2023 | 2.93 Mn |
| Mar 31, 2023 | 2.07 Mn |
| Dec 31, 2022 | 991,000.00 |
| Sep 30, 2022 | 973,000.00 |
| Jun 30, 2022 | 984,000.00 |
| Mar 31, 2022 | 556,000.00 |
| Dec 31, 2021 | 568,000.00 |
| Sep 30, 2021 | 994,000.00 |